SEC – ‘UPLOAD’ from 8/9/19 re: Acasti Pharma Inc. – ‘TEXT-EXTRACT’

On:  Friday, 8/9/19, at 9:09am ET   ·   Delayed-Release:  Filing ¶  –  Release Delayed to:  9/10/19   ·   Accession #:  0-19-12252

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Delayed-Release Comment or Other Letter from the SEC
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: LETTER      Comment or Other Letter from the SEC                 PDF     32K 
 2: TEXT-EXTRACT  Comment or Other Letter from the SEC (PDF Text)      1      6K 

‘TEXT-EXTRACT’   —   Comment or Other Letter from the SEC (PDF Text)

                                                      August 8, 2019

Janelle D'Alvise                                                                
Chief Executive Officer                                                         
Acasti Pharma Inc.                                                              
545 Promenade du Centropolis, Suite 100                                         
Laval, Qu bec, Canada H7T 0A3                                                   

Re: Acasti Pharma Inc.                                            
Registration Statement on Form F-3                        
Filed August 7, 2019                                      
File No. 333-233063                                       

Dear Ms. D'Alvise:                                                              

      This is to advise you that we have not reviewed and will not review your
registration                                                                    
statement.                                                                      

      Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you                                                                   
that the company and its management are responsible for the accuracy and        
adequacy of their                                                               
disclosures, notwithstanding any review, comments, action or absence of action  
by the staff.                                                                   

    Please contact Christine Westbrook at 202-551-5019 with any questions.

                                                  Sincerely,

                                                   Division of
Corporation Finance                                                             
                                                 Office of
Healthcare & Insurance                                                          
cc:    Jason Comerford, Esq.                                                    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘UPLOAD’ Filing		Date		Other Filings
Release Delayed to:		9/10/19		CORRESP,  UPLOAD
Filed on:		8/9/19		6-K,  CORRESP,  EFFECT,  UPLOAD
		8/8/19		CORRESP,  UPLOAD
		8/7/19		6-K,  F-3,  UPLOAD
				List all Filings

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/07/19  Acasti Pharma Inc.                F-3         8/06/19    4:383K                                   Globenewswire Inc./FA